SynthesisFrontiers in cardiovascular medicine2024

The efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors combined with statins in patients with hypercholesterolemia: a network meta-analysis.

Dong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.